Related Content
March 28, 2026 — Amgen announced today that Repatha (evolocumab), when added to statins or other low-density lipoprotein ...
April 06, 2026
Aug. 25, 2025 — Amgen has announced that the U.S. Food and Drug Administration (FDA) has broadened the approved use of ...
August 26, 2025
September 12, 2023 — The American College of Cardiology, through a strategic collaboration with Amgen and Esperion, is ...
September 12, 2023
March 4, 2022 – NewAmsterdam Pharma (NAP), a clinical-stage company focused on the research and development of ...
March 04, 2022
May 18, 2021 — The experimental heart failure drug omecamtiv mecarbil reduced heart failure hospitalizations by a ...
May 18, 2021
October 31, 2018 — Amgen announced a new Repatha cardiovascular outcomes study (FOURIER) analysis evaluating the effects ...
October 31, 2018
April 3, 2017 — There is no evidence that adding a new cholesterol-lowering drug to treatment with a statin causes ...
April 03, 2017
March 20, 2017 — The most important late-breaking pharmaceutical trial at the 2017 America College of Cardiology annual ...
March 20, 2017
April 16, 2015 — The U.S. Food and Drug Administration (FDA) approved Amgen’s ivabradine (Corlanor) to reduce ...
April 16, 2015